Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03468400 · ClinicalTrials.gov registry record
Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire
A clinical trial of Insomnia and Sleep Apnea Syndromes, sponsored by Dayzz Live Well.
- Completed
- Registry status
- 250
- Enrollment target
- 2
- Study locations
NCT03468400: Completed study of Insomnia and Sleep Apnea Syndromes, sponsored by Dayzz Live Well.
NCT03468400 is a study of Insomnia and Sleep Apnea Syndromes that has completed, run by Dayzz Live Well. The registered enrollment target is 250 participants, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (48% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03468400, a study of Insomnia and Sleep Apnea Syndromes, has completed, sponsored by Dayzz Live Well.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study aims to develop and test a user-friendly, accessible approach to sleep assessment which can function as an initial "triage" of targeted sleep conditions, such as insomnia, insufficient sleep syndrome, sleep apnea syndromes/snoring, and circadian sleep/wake disorders, within the clinical and community population. Specifically, this study will test the validity and reliability of a self-rated, digitized, and cost-effective diagnostic measure with sufficient sensitivity to accurately assess/diagnose common sleep conditions and/or risk for these conditions. Such an approach, would allow for faster assessment of common sleep conditions and disorders, and provide clinical knowledge to the individual, the physician, and if required insurance companies, as to those persons who need more immediate attention or treatment for their sleep condition.
Primary Outcome
Dayzz diagnostic sleep questionnaire (dDSQ): Insomnia, insufficient sleep syndrome, circadian sleep/wake disorders, risk for sleep apnea, snoring
Conditions Studied
Study Locations (2)
Maryland
- John Hopkins University - Baltimore
Other
- Carmel Hospital - Haifa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-09-30 |
What the finished NCT03468400 record still lists
NCT03468400 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (48% higher).
The record links to 4 conditions, with Insomnia appearing as the primary indexed condition, and to 0 interventions.
NCT03468400 reports a single indexed study location in Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT03468400 about?
NCT03468400 is a clinical study titled "Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire". The study aims to develop and test a user-friendly, accessible approach to sleep assessment which can function as an initial "triage" of targeted sleep conditions, such as insomnia, insufficient sleep syndrome, sleep apnea syndromes/snoring, and circadian sleep/wake disorders, within the clinical an...
What is the current status of trial NCT03468400?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2018-03-01. Estimated completion is 2019-09-30.
What conditions does trial NCT03468400 study?
This clinical trial studies the following conditions: Insomnia, Sleep Apnea Syndromes, Circadian Rhythm Disorders, Insufficient Sleep Syndrome.
Who is sponsoring clinical trial NCT03468400?
This trial is sponsored by Dayzz Live Well, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03468400 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03468400's enrollment target sits among peer trials
250 28th of 151 higher than 123 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
RECRUITING
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Pimavanserin for Insomnia in Veterans With PTSD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI